Maricann Group Inc’s Drug Delivery Technology Sets Us Apart: Director

Maricann Group Inc. (CSE:MARI) Director of Investor Relations says the Company plans to be active in Western Europe



In this interview with SmallCapPower at the recent Benzinga Cannabis Capital Conference in Toronto, Maricann Group Inc. (CSE:MARI) Director of Investor Relations Graham Farrell outlines the investment case for this fully-integrated licensed cannabis producer, which includes a patent-protected cannabis drug delivery technology and some soon-to-be-disclosed European plans.

To read our full disclosure, please click on the button below: